The peptide problem: Hype is outrunning the evidence FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step We have received an uptick in questions related to this substance. We felt it was best to share our policy here to bring attention to it. . OCB adheres to WADA guidelines RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn